Quinlan J J, Gallaher E J, Firestone L L
Department of Anesthesiology and Critical Care Medicine, University of Pittsburgh, PA 15261.
Brain Res. 1993 May 7;610(2):224-8. doi: 10.1016/0006-8993(93)91404-g.
The DS (diazepam-sensitive) and DR (diazepam-resistant) lines of mice, selected on the basis of their ataxic response to diazepam, also diverge in the physiologic response of their brain gamma-aminobutyric acidA (GABAA) receptors to benzodiazepines, as indicated by augmentation of GABA-mediated chloride flux. Cross-sensitivity and -resistance to other sedatives known to interact with the GABAA-receptor have also been demonstrated in DS and DR mice. Based on the finding that these mice also show cross-sensitivity and -resistance to obtundation by halothane, we predicted that their GABAA-receptors would also exhibit a differential response to halothane as assayed by an in vitro 36Cl- influx assay using purified brain microvesicles. Consistent with this prediction, therapeutic concentrations of halothane enhanced 1 mumol/l GABA-gated flux with significantly greater potency in DS than in DR mice (halothane EC50 336 +/- 64 mumol/l (S.E.M.) vs. 605 +/- 110 mumol/l, respectively, P = 0.03), but there was no difference in maximal flux enhancement between the two lines (DS 4.7 +/- 0.4 nmol.mg-1 x 3 s-1, vs. DR 4.7 +/- 0.5 nmol.mg-1 x 3 s-1). Halothane (500 mumol/l) also shifted the entire GABA concentration-flux relationship significantly to the left, decreasing the EC50 for GABA in both the DS and DR lines. Importantly, the shift in the GABA concentration-flux response in the presence of halothane was more pronounced in the DS mice (GABA EC50 1.8 +/- 0.4 mumol/l vs. 14.7 +/- 0.9 mumol/l without halothane) than in the DR mice (GABA EC50 4.7 +/- 0.6 mumol/l vs. 14.7 +/- 0.9 mumol/l without halothane).(ABSTRACT TRUNCATED AT 250 WORDS)
根据小鼠对安定的共济失调反应挑选出的安定敏感(DS)和安定抵抗(DR)品系,其脑γ-氨基丁酸A(GABAA)受体对苯二氮䓬类药物的生理反应也存在差异,这可通过GABA介导的氯通量增加来表明。DS和DR小鼠对已知与GABAA受体相互作用的其他镇静剂也表现出交叉敏感性和交叉抗性。基于这些小鼠对氟烷致昏迷也表现出交叉敏感性和交叉抗性这一发现,我们预测它们的GABAA受体对氟烷也会表现出不同反应,这可通过使用纯化脑微囊泡的体外36Cl-流入试验来测定。与这一预测一致,治疗浓度的氟烷增强了1μmol/L GABA门控通量,在DS小鼠中的效力显著高于DR小鼠(氟烷的半数有效浓度[EC50]分别为336±64μmol/L[标准误]和605±110μmol/L,P = 0.03),但两品系之间的最大通量增强无差异(DS为4.7±0.4 nmol·mg-1×3 s-1,DR为4.7±0.5 nmol·mg-1×3 s-1)。氟烷(500μmol/L)也使整个GABA浓度-通量关系显著向左移动,降低了DS和DR品系中GABA的EC50。重要的是,在氟烷存在下,GABA浓度-通量反应的变化在DS小鼠中(有氟烷时GABA的EC50为1.8±0.4μmol/L,无氟烷时为14.7±0.9μmol/L)比在DR小鼠中(有氟烷时GABA的EC50为4.7±0.6μmol/L,无氟烷时为14.7±0.9μmol/L)更明显。(摘要截短于250字)